PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Radiation Oncology Journal10.3857/roj.2019.00017201937113-21National trends in radiation dose escalation for glioblastomaRodney E. Wegner, Stephen Abel, Zachary D. Horne, Shaakir Hasan, Vivek Verma, Tulika Ranjan, Richard W. Williamson, Stephen M. Karlovitshttp://e-roj.org/upload/pdf/roj-2019-00017.pdf, http://e-roj.org/journal/view.php?doi=10.3857/roj.2019.00017, http://www.e-roj.org/upload/pdf/roj-2019-00017.pdf
International Journal of Radiation Oncology*Biology*Physics10.1016/j.ijrobp.2012.07.18602012843S696Pulsed Low-dose-rate Versus Standard Irradiation in Orthotopic Glioblastoma Multiforme: Dose-Escalation, Functional Imaging, and the Small Animal Radiation Research PlatformJ.T. Dilworth, S.A. Krueger, M.B. Dabjan, J. Torma, T.J. Geddes, I.S. Grills, G.D. Wilson, B. Marpleshttps://api.elsevier.com/content/article/PII:S0360301612028040?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0360301612028040?httpAccept=text/plain
International Journal of Radiation Oncology*Biology*Physics10.1016/j.ijrobp.2014.05.5272014901S109Feasibility of Extreme Dose Escalation for Glioblastoma Multiforme Using 4π Radiation TherapyD. Nguyen, J. Rwigema, V.Y. Yu, T. Kaprealian, P. Kupelian, M.T. Selch, D. Low, K. Shenghttps://api.elsevier.com/content/article/PII:S036030161401178X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S036030161401178X?httpAccept=text/plain
International Journal of Radiation Oncology*Biology*Physics10.1016/s0360-3016(01)02200-32001513205A Phase I dose escalation trial of motexafin gadolinium (gadolinium texaphyrin, xcytrinR)as a radiation sensitizer in patients with newly diagnosed glioblastoma multiformeJ.M. Ford, T. Endicott, J.R. Alger, J. Earle, D. Miles, S. Phanhttps://api.elsevier.com/content/article/PII:S0360301601022003?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0360301601022003?httpAccept=text/plain
Oxford Medical Case Reports10.1093/omcr/omz085201920199Presentation of treatment effect in glioblastoma after dose-escalation radiation therapyDanielle Cicka, Charles Lester Ford, Erica Templin, Zachary Pitts, Saumya Gurbani, Bree Eaton, Lindsey Lowder, Jeffrey Olson, Brent D Weinberg, Hyunsuk Shim, Soma Senguptahttp://academic.oup.com/omcr/article-pdf/2019/9/omz085/30072721/omz085.pdf
Radiation Oncology10.1186/s13014-014-0239-x201491Feasibility of extreme dose escalation for glioblastoma multiforme using 4π radiotherapyDan Nguyen, Jean-Claude M Rwigema, Victoria Y Yu, Tania Kaprealian, Patrick Kupelian, Michael Selch, Percy Lee, Daniel A Low, Ke Shenghttp://link.springer.com/content/pdf/10.1186/s13014-014-0239-x.pdf, http://link.springer.com/article/10.1186/s13014-014-0239-x/fulltext.html, http://link.springer.com/content/pdf/10.1186/s13014-014-0239-x, https://link.springer.com/content/pdf/10.1186/s13014-014-0239-x.pdf
Radiotherapy and Oncology10.1016/s0167-8140(02)83301-1200264S292993 Poster Novel approaches for dose escalation in radiotherapy of glioblastoma: first clinical experiencehttps://api.elsevier.com/content/article/PII:S0167814002833011?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0167814002833011?httpAccept=text/plain
International Journal of Radiation Oncology*Biology*Physics10.1016/j.ijrobp.2005.07.455200563S265-S266A Phase I Study of Accelerated Radiotherapy for Glioblastoma Multiforme Using Stereotactic Concomitant Boosts for Dose EscalationT. Chung, T. Wallace, R. Cardinale, W. Broaddus, S. Benedict, V. Ramekrishnan, R. Schmidt-Ullrichhttps://api.elsevier.com/content/article/PII:S0360301605016408?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0360301605016408?httpAccept=text/plain
International Journal of Radiation Oncology*Biology*Physics10.1016/j.ijrobp.2012.07.7092012843S272NTCP Modeling of Dose-escalation Hypofractionated Stereotactic Radiation Therapy (HFSRT) for Patients With Subtotally Resected (STR) Newly Diagnosed Glioblastoma Multiforme (GBM)M. Yondorf, S. Wang, L. Zhou, J. Chang, P. Desai, B. Parashar, D. Nori, K. Chao, A. Wernickehttps://api.elsevier.com/content/article/PII:S0360301612016537?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0360301612016537?httpAccept=text/plain
International Journal of Radiation Oncology*Biology*Physics10.1016/j.ijrobp.2009.07.2982009753S124Phase 1 TITE-CRM Dose Escalation Study of Concurrent Temozolomide and Intensity Modulated Radiation Therapy in Newly Diagnosed Glioblastoma MultiformeD.R. Brown, D. Normolle, L.R. Junck, T.S. Lawrence, J.A. Heth, J.A. Hayman, R.K. Ten Haken, T. Chenevert, M.R. Piert, C.I. Tsienhttps://api.elsevier.com/content/article/PII:S0360301609013406?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0360301609013406?httpAccept=text/plain